SAN DIEGO – ResMed Inc revenue for the quarter ended Sept 30, 2014, was $380.4 million, a 6% increase compared to the same period last year. Net income was $83.3 million, an increase of 3% compared to last year. “We had a successful start to fiscal year 2015, as new product launches drove revenue growth,” said Mick Farrell, ResMed’s CEO. “Our results showed very strong performance from our European and Asia Pacific regions, as well as solid growth in the Americas.
“During the quarter, we launched innovative products for the sleep-disordered breathing market, including our new AirSense 10 platform, as well as a new life support ventilator for the U.S. respiratory care market, our new Astral platform,” added Farrell. “We have also recently made progress in building consumer awareness an education and product-focused campaign called ‘Better Sleep for Women’; and the launch of ‘S+ by ResMed’, the first non-contact sleep wellness tracking device for individuals.”
In the first quarter of fiscal year 2015, the San Diego-based company reports that revenue outside the Americas was $173.2 million, an 11% increase over the prior year’s quarter (also an 11% increase on a constant currency basis). Revenue in the Americas was $207.2 million, a 3% increase compared to $201.5 million in the prior year’s quarter.
